Clinical Trial

Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial

Study acronym: FIL_FOLL-BIO
Recruiting
View on ClinicalTrials.gov →
Summary
This is a Multicenter, Retrospective, Biological study ancillary to FOLL12 trial to evaluate the role of EZH2 aberrations in patient with FL treated with immunochemotherapy. Moreover, several novel biomarkers of FL will be investigated.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-04-04; most recent amendment 2025-12-22.
Status change: Not Yet Recruiting → Recruiting 2023-12-27
Trial Details
NCT Number NCT05816850
Lead Sponsor Fondazione Italiana Linfomi - ETS
Conditions Follicular Lymphoma
Enrollment 654 participants
Start Date 2023-09-19
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-29